Event Brief
Gilead nears $2bn deal for autoimmune biotech Ouro Medicines
Filed: Mar 23, 2026 at 1:06 PM ET
Summary: Gilead Sciences plans to acquire Ouro Medicines for up to $2 billion, leveraging its rising share price.
WHO: Gilead Sciences
WHAT: acquisition of Ouro Medicines
WHEN: Mar 23, 2026 at 12:33 PM ET
WHERE: California
WHY: to take advantage of surging share price for takeovers
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →